Hertford, United Kingdom

Veronique Birault



Average Co-Inventor Count = 10.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Warren Terrace, GB (2011)
  • Hertford, GB (2011 - 2012)

Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Veronique Birault: Innovator in Pharmaceutical Compounds

Introduction

Veronique Birault is a distinguished inventor based in Hertford, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating degenerative and inflammatory diseases. With a total of 4 patents to her name, her work has the potential to impact the lives of many.

Latest Patents

Among her latest innovations are novel imidazo[1,2-a]pyrazine compounds. These compounds are disclosed for their utility in the treatment of various conditions, including arthritis and inflammation. The pharmaceutical compositions derived from these compounds may be used for the prevention and treatment of a variety of conditions in mammals, including humans.

Career Highlights

Veronique has worked with notable companies in the pharmaceutical industry, including Janssen Pharmaceutica NV and Galapagos NV. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking research.

Collaborations

Throughout her career, Veronique has collaborated with esteemed colleagues such as Martin James Inglis Andrews and Paul John Edwards. These partnerships have fostered an environment of innovation and creativity in her work.

Conclusion

Veronique Birault's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her as a key figure in the development of treatments for degenerative and inflammatory diseases. Her work continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…